SCINAI IMMUNOTHERAPEUTICS LTD. Retained Earnings
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Retained Earnings of -$125.85 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-04-01
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$125.85M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$121.67M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$117.54M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$126.82M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$125.85M 20-F · filed 2026-04-01 |
| 2025-06-30 | -$121.67M 6-K · filed 2025-09-02 |
| 2024-12-31 | -$117.54M 20-F · filed 2026-04-01 |
| 2024-06-30 | -$126.82M 6-K · filed 2024-09-09 |
| 2023-12-31 | -$122.33M 20-F · filed 2025-05-07 |
| 2023-06-30 | -$123.11M 6-K/A · filed 2023-08-18 |
| 2023-03-31 | -$119.35M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$115.83M 20-F · filed 2024-05-15 |
| 2021-12-31 | -$110.04M 10-K · filed 2023-04-17 |